Supriya Lifescience Limited

Supriya Lifescience Limited (SUPRIYA) is a small-cap Healthcare company valued at ₹7,129 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Supriya Lifescience Limited last traded at ₹886, modestly up 1.54% on the day.

Recent developments

On 2026-09-04, the company announced a dividend of ₹1.00 per share, ex-date. Promoter holding remained at 68.30% as of 2026-06-30, while foreign institutional holding increased by 1.03 percentage points and domestic institutional holding decreased by 0.40 percentage points.

Financial performance

The company's business has grown, with annual revenue rising 18.9% and net profit increasing 11.2% year-over-year. However, the latest quarter shows a sharp decline in net profit, which fell 31.3% compared to the same quarter a year earlier, despite revenue rising 30.9%.

Valuation multiples

The stock trades at 34.1 times earnings, broadly in line with the Healthcare median of 32.0, 6.17 times book value. It yields 0.1%.

Things to watch

The company's net profit margin narrowed by 1.8 percentage points to 25.3%. The latest quarter's net profit dropped 31.3% compared to the same quarter a year earlier, despite revenue growth. The stock is 14.2% below its 52-week high.

Where it stands

The company has shown strong revenue growth over the past three years, but recent quarterly results highlight a decline in profitability. The stock is trading 14.2% below its 52-week high, and the net profit margin has narrowed. The latest quarter's net profit fell 31.3% compared to the same quarter a year earlier.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.